Domestic pharmaceutical companies tighten Compliance Program due to multinational companies

Although domestic pharmaceutical companies have recently tightened Compliance Program in series, one of their reasons for the phenomenon was known to establish partnership with multinational pharmaceutical companies.

Since the Rebate Two-Out System has been enforced since July 2014 and enactment of the Young-lan Kim Act was expected, multinational companies which branched in Korea have started...